Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP923466.RAOSk3MnJJz3Jhrh1g2sJPqs9EMG8b3Yq_M3cK9SbmPB8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP923466.RAOSk3MnJJz3Jhrh1g2sJPqs9EMG8b3Yq_M3cK9SbmPB8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP923466.RAOSk3MnJJz3Jhrh1g2sJPqs9EMG8b3Yq_M3cK9SbmPB8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP923466.RAOSk3MnJJz3Jhrh1g2sJPqs9EMG8b3Yq_M3cK9SbmPB8130_provenance.
- NP923466.RAOSk3MnJJz3Jhrh1g2sJPqs9EMG8b3Yq_M3cK9SbmPB8130_assertion description "[The ability to suppress the malignant phenotype by downregulating cyclin D1 expression may provide a new gene therapy approach for patients with malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923466.RAOSk3MnJJz3Jhrh1g2sJPqs9EMG8b3Yq_M3cK9SbmPB8130_provenance.
- NP923466.RAOSk3MnJJz3Jhrh1g2sJPqs9EMG8b3Yq_M3cK9SbmPB8130_assertion evidence source_evidence_literature NP923466.RAOSk3MnJJz3Jhrh1g2sJPqs9EMG8b3Yq_M3cK9SbmPB8130_provenance.
- NP923466.RAOSk3MnJJz3Jhrh1g2sJPqs9EMG8b3Yq_M3cK9SbmPB8130_assertion SIO_000772 21912938 NP923466.RAOSk3MnJJz3Jhrh1g2sJPqs9EMG8b3Yq_M3cK9SbmPB8130_provenance.
- NP923466.RAOSk3MnJJz3Jhrh1g2sJPqs9EMG8b3Yq_M3cK9SbmPB8130_assertion wasDerivedFrom befree-2016 NP923466.RAOSk3MnJJz3Jhrh1g2sJPqs9EMG8b3Yq_M3cK9SbmPB8130_provenance.
- NP923466.RAOSk3MnJJz3Jhrh1g2sJPqs9EMG8b3Yq_M3cK9SbmPB8130_assertion wasGeneratedBy ECO_0000203 NP923466.RAOSk3MnJJz3Jhrh1g2sJPqs9EMG8b3Yq_M3cK9SbmPB8130_provenance.
- befree-2016 importedOn "2016-02-19" NP923466.RAOSk3MnJJz3Jhrh1g2sJPqs9EMG8b3Yq_M3cK9SbmPB8130_provenance.